MENU
EYEN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Eyenovia (EYEN) Ownership - Who owns Eyenovia?
Eyenovia Inc is a clinical-stage ophthalmic company developing a pipeline of therapeutics based on its proprietary array print (MAP) platform technology... Show more
Industry: #Pharmaceuticals Major
Profile
Industry
Pharmaceuticals Major
Address
295 Madison Avenue
Phone
+1 833 393-6684
Employees
57
Web
https://www.eyenovia.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
27.53M
P/E Ratio
N/A
Total Cash
3.93M
Projected Growth
N/A
Total Debt
11.15M
Revenue
67.06K
Risk (Beta)
0.60
Dividend Yield
N/A
Total Cash/Share
1.36
Total Debt/Equity
N/A
Revenue/Share
0.05 USD as % of share price
Fundamentals
EYEN
Capitalization
27.5M
P/E Ratio
N/A
Risk (Beta)
0.60
Dividend Yield
N/A
Total Cash
3.94M
Total Cash/Share
1.36
Total Debt
11.1M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.05%
Revenue
67.1K
ROE
N/A
Book Value
-9.71M
P/B Ratio
0.57
Cash Flow
N/A
Earnings
-42.65
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
283
Current Ratio
0.34
Current Revenue Per Employee
258.25
Dividends Per Share - Security
N/A
EBITDA
-39.11M
Float
N/A
Float - Current
N/A
Gross Income Margin
99.67
Revenue To Assets
-263.55
Shares Held By Institutions
842K
Shares Outstanding - Current
2.88M
Total Liabilities
15.7M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-18.236
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a company which delivers sight saving therapies
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
295 Madison Avenue
Phone
+1 833 393-6684
Employees
57
Web
https://www.eyenovia.com